Meta-analysis of the association of anemia, chronic kidney disease (CKD), and cardiovascular disease (CVD)

被引:0
|
作者
Levy, W [1 ]
Badamgarav, E [1 ]
Kewalramani, R [1 ]
Song, P [1 ]
Agodoa, I [1 ]
Nora, J [1 ]
Dubois, R [1 ]
Lepor, N [1 ]
机构
[1] Cerner Hlth Insights, Beverly Hills, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:260A / 260A
页数:1
相关论文
共 50 条
  • [21] ORAL DISEASE IN PEOPLE WITH CHRONIC KIDNEY DISEASE: META-ANALYSIS OF PREVALENCE AND ASSOCIATION WITH CLINICAL OUTCOMES
    Ruospo, Marinella
    Palmer, Suetonia
    Vecchio, Mariacristina
    Gargano, Letizia
    Petruzzi, Massimo
    De Benedictis, M.
    Pellegrini, Fabio
    Strippoli, Giovanni
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 394 - 395
  • [22] Cardiovascular properties in children with chronic kidney disease (CKD)
    Haseler, Emily
    Chowienczyk, Phil
    Gu, Haotian
    Li, Ye
    Sinha, Manish
    PEDIATRIC NEPHROLOGY, 2023, 38 (07) : 2377 - 2378
  • [23] Hemoglobin targets for the anemia of chronic kidney disease: A meta-analysis of randomized, controlled trials
    Strippoli, GFM
    Craig, JC
    Manno, C
    Schena, FP
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (12): : 3154 - 3165
  • [24] The influence of chronic kidney disease (CKD) on cardiovascular disease (CVD) risk factors in a multi-ethnic UK population
    Crasto, W.
    Srinivasan, B. T.
    Jarvis, J.
    Brela, J.
    Taub, N.
    Harris, K.
    Khunti, K.
    Davies, M. J.
    DIABETIC MEDICINE, 2008, 25
  • [25] Hemoglobin Targets for Chronic Kidney Disease Patients with Anemia: A Systematic Review and Meta-analysis
    Zhou Jing
    Yuan Wei-jie
    Zhu Nan
    Zhou Yi
    Wang Ling
    PLOS ONE, 2012, 7 (08):
  • [26] Assessment of the safety of Roxadustat for cardiovascular events in chronic kidney disease-related anemia using meta-analysis and bioinformatics
    Li, Xiangmeng
    Jiang, Shimin
    Gu, Xia
    Liu, Xiaojing
    Shang, Shunlai
    Zhang, Jiao
    Pang, Keying
    Li, Wenge
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [27] Safety and effectiveness of lanthanum carbonate for hyperphosphatemia in chronic kidney disease (CKD) patients: a meta-analysis
    Zhao, Lijuan
    Liu, An
    Xu, Guoshuang
    RENAL FAILURE, 2021, 43 (01) : 1378 - 1393
  • [28] Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study
    Boyd, Mark A.
    Mocroft, Amanda
    Ryom, Lene
    Monforte, Antonella d'Arminio
    Sabin, Caroline
    El-Sadr, Wafaa M.
    Hatleberg, Camilla Ingrid
    De Wit, Stephane
    Weber, Rainer
    Fontas, Eric
    Phillips, Andrew
    Bonnet, Fabrice
    Reiss, Peter
    Lundgren, Jens
    Law, Matthew
    PLOS MEDICINE, 2017, 14 (11):
  • [29] Impact of anemia correction with an erythropoiesis stimulating protein (ESP) on renal function in chronic kidney disease (CKD) patients not on dialysis: A meta-analysis
    Lea, J
    Kawalramani, R
    Agodoa, I
    Nora, J
    Pinto, L
    Badamgarav, E
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (04) : A39 - A39
  • [30] Treatment patterns of anemia in patients with chronic kidney disease (CKD).
    Rao, M
    Pereira, B
    Scarlata, D
    Brenner, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 816A - 816A